John Sperzel

John Sperzel

No más puestos en curso

Fortuna: - $ al 31/05/2026

62 años
Health Technology
Consumer Services

Perfil

John J.
Sperzel
formerly worked at Chembio Diagnostics, Inc., as President, Chief Executive Officer & Director from 2014 to 2017, Chembio Diagnostics, Inc., as President, CEO & Independent Director from 2014 to 2020, ITC Nexus Holding Co., Inc., as Chief Executive Officer from 2011 to 2013, Chembio Diagnostic Systems, Inc., as President, Chief Executive Officer & Director, International Technidyne Corp., as President & Chief Executive Officer from 2011 to 2013, T2 Biosystems, Inc., as Chairman, President & Chief Executive Officer from 2021 to 2025, Diadexus, Inc., as Director, Ontera, Inc., as Director, Bayer Diagnostics Corp., as President-Marketing & Business Development from 2000 to 2009, Axis-Shield Ltd., as President-USA, and Roche Diagnostics Corp., as Vice President from 1987 to 1997.
Mr. Sperzel received his undergraduate degree from Plymouth State University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
07/01/2025 400 ( 0 % ) 0 $ 31/05/2026

Antiguos cargos conocidos de John Sperzel.

EmpresasCargoFin
T2 BIOSYSTEMS, INC. Director Ejecutivo 31/03/2025
CHEMBIO DIAGNOSTICS, INC. Director Ejecutivo 09/01/2020
CHEMBIO DIAGNOSTICS, INC. Director Ejecutivo 30/05/2017
Director Ejecutivo 01/12/2013
Director Ejecutivo 01/12/2013
Ver el detalle de la experiencia de John Sperzel.

Formación de John Sperzel.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

43

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology